Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001086734 | SCV000641678 | benign | Tuberous sclerosis 1 | 2025-01-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000572956 | SCV000675395 | likely benign | Hereditary cancer-predisposing syndrome | 2022-11-30 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Athena Diagnostics | RCV000713912 | SCV000844556 | uncertain significance | not provided | 2017-09-11 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000713912 | SCV001766431 | uncertain significance | not provided | 2021-01-21 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant does not alter protein structure/function; In silico analysis suggests this variant may impact gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown. |
Genome- |
RCV001086734 | SCV002040137 | uncertain significance | Tuberous sclerosis 1 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Greenwood Genetic Center Diagnostic Laboratories, |
RCV000713912 | SCV005200855 | uncertain significance | not provided | 2024-06-03 | criteria provided, single submitter | clinical testing | PM2, PP2 |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000713912 | SCV005624766 | uncertain significance | not provided | 2024-03-08 | criteria provided, single submitter | clinical testing |